GLOBAL GLUCOSE MONITORING SYSTEM (CGMS & SMBG) MARKET FORECAST 2017-2025

  • You are here:
  • Home
  • Reports
  • GLOBAL GLUCOSE MONITORING SYSTEM (CGMS & SMBG) MARKET FORECAST 2017-2025

GLOBAL GLUCOSE MONITORING SYSTEM (CGMS & SMBG) MARKET FORECAST 2017-2025

The global glucose monitoring system market consists of continuous glucose monitoring market (CGMS) and self-monitoring of blood glucose (SMBG) market. The CGMS market is anticipated to grow from $ 878 million in 2016 to $13672 million by 2025, at a CAGR of 36.72% between 2016 and 2025. Whereas, the SMBG market is anticipated to grow from $12481 million in 2016 to $20563 million by 2025. Continuous glucose monitoring (CGM) device is a system used for measuring glucose levels in the interstitial fluid that is present between the cells of the skin. 

GLOBAL GLUCOSE MONITORING SYSTEM (CGMS & SMBG) MARKET FORECAST 2017-2025

Glucose Monitoring System (CGMS & SMBG) Market by Component Type (Sensors, Transmitters & Receivers, Insulin Pump) by Application (Home Settings, Diagnostics and Clinics, Hospitals) by Component Type (Test Strips, Glucose Meter) by Application (by Application, Clinics, Hospitals) by Geography

Request free sample

The global glucose monitoring system market consists of continuous glucose monitoring market (CGMS) and self-monitoring of blood glucose (SMBG) market. The CGMS market is anticipated to grow from $ 878 million in 2016 to $13672 million by 2025, at a CAGR of 36.72% between 2016 and 2025. Whereas, the SMBG market is anticipated to grow from $12481 million in 2016 to $20563 million by 2025. Continuous glucose monitoring (CGM) device is a system used for measuring glucose levels in the interstitial fluid that is present between the cells of the skin. Whereas, self-monitoring of blood glucose (SMBG) refers to the monitoring of glucose level personally using SMBG devices available in the market. The following factors primarily driving the glucose monitoring system market are:

  • Increase in diabetic population
  • Increase in healthcare expenditure
  • Increasing focus on research and development
  • Integration of technology
  • Increasing CGMS affordability
  • Low price of technology

Glucose monitoring system (CGMS & SMBG ) market infographicIncrease in diabetic population and increase in healthcare expenditure are the important drivers propelling the growth of the global glucose monitoring system market. Diabetes population has seen an exponential rise. Changes in lifestyles, eating habits, and reduced physical workout have led to rising in obesity, which is the major cause of type 2 Diabetes in the adults. Type 1 Diabetics cases are also increasing at a rapid pace. Global expenditure on diabetes increased to more than $935 billion (2015), which is 9-10% of the total health expenditure.

The applications of glucose monitoring system market are used extensively for varied purposes. The home settings segment in the CGMS market is the largest segment contributing more than 90% to the overall CGMS market. Professional CGMS are used by doctors to study the glucose level variation in the patients. The market of CGMS devices in clinics and hospital is limited, as these devices are still in the development and approval phase. SMBG is used by individuals personally. The frequency of SMBG depends on the type of medical therapy, risk for hypoglycemia, and need for short-term adjustment of therapy. The market for clinical and hospital use of SMBG devices is limited, as these devices are used at home, and the numbers of devices are limited.

Hindrance from government regulations and lack of knowledge are the major factors hindering the growth of the glucose monitoring system market. Glucose monitoring system is a highly regulated market. It faces stringent regulations and approval issues from government authorities. Especially the US FDA has very strict regulations. Many diabetologists are unwilling to use CGM in their practices as taking the precaution of patients using this technology is rather time-consuming. Patients not only have frequent queries about the systems, but also data download, troubleshooting, and interpretation can be unwieldy.

The global glucose monitoring system market is segmented into Component types and applications.

  • CGMS market by component type
  • Sensors
  • Transmitters and receivers
  • Insulin pump
  • CGMS market by application
  • Home settings
  • Diagnostics and clinics
  • Hospitals
  • SMBG market by component type
  • Test strips
  • Glucose meter
  • Others
  • SMBG market by application
  • Home settings
  • Clinics
  • Hospitals

This report covers the present market conditions and the growth prospects of the global glucose monitoring system market for 2017-2025. The report considers the revenue generated through the sales of glucose monitoring system market by components types as well as applications. To calculate the market size the base year considered is 2016.

Geographically, the global glucose monitoring system market has been segmented into four major regions, which include:

  • North America – United states & Canada
  • Asia-Pacific – China, India, Australia, Rest of APAC
  • Europe – United Kingdom, France, Germany, Rest of Europe
  • Latin America
  • Rest of World

The glucose monitoring system market in North America is expected to hold the largest share by 2025. The US tops the current GMS market. The top two GMS manufacturers are American companies. The U.S currently accounts for 75-80% of total product revenues in the GMS market. Canada is one of the most developed nations and has the eighth highest per capita income in the world. People from various races and ethnic groups reside in Canada, which is vastly populated by aboriginal people. On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the glucose monitoring system market. The last three decades have witnessed an epidemic/extensive increase in the number of diabetic patients, specifically type 2 diabetes and particularly in developing economies where more than 80% of the people suffer from diabetes. The increasing prevalence rate of type 2 diabetes in South Asia is anticipated to be more than 150% during 2000-2035.

The glucose monitoring system market is segmented based on Component types.  The CGMS component types are sub-divided into sensors, transmitter, and receivers, and integrated insulin pumps and SMBG component types are sub-divided on the basis of strips, glucose meter, and others. The CGMS sensor is used to measure interstitial or blood glucose levels. They are small 9 mm devices, inserted into the subcutaneous layer of the abdomen, and are approved to use for six to seven days. Most of the CGM devices secure transmitter to the skin and the sensor so that the position of it is fixed and it doesn’t move around. Integrated insulin pumps are devices with an integrated CGMS. The blood glucose test strips (diabetes test strips) are the key component of blood glucose testing. A glucose meter is a medicinal device that estimates the concentration of glucose in the plasma. The other component type used in self glucose monitoring includes lancets and other small devices.

The major market players in the global glucose monitoring system market are:

  • ABBOTT
  • DEXCOM
  • TANDEM DIABETES CARE
  • ROCHE DIAGNOSTICS
  • GLYSENS INC

Abbot diagnostic, a manufacturer of in vitro diagnostics, offers a range of medical instruments, tests, and systems for clinics and hospitals. Abbot technology also develops, manufactures and supply products in vitro diagnostics market. Glysens is established in 1997 and is located in San Diego, California. It is a biomedical technology company which develops glucose monitoring devices for the treatment of diabetes. The enrich product portfolio enables and helps to check the blood glucose level, gives automatic warnings when the glucose is at a low level or high level and also shows historical charts of blood glucose values.

Key Findings of the global glucose monitoring system market:

  • Asia Pacific market has been showing the strongest growth for the GMS market
  • Self-monitoring of blood glucose is an extremely lucrative business with huge market opportunity
  • Companies are collaborating to develop integrated CGMS-enabled insulin pumps
  • Sensors and transmitters contribute almost 90% of the total CGMS market by Product
  • Testing strips and glucose meter contribute to nearly 95% of the SMBG market by Type

Major players for the Glucose monitoring market are Medtronic, Dexcom, Abbott, Johnson and Johnson, Insulet corp., Tandem Diabetes, Echo Therapeutics, Roche Diagnostics, Nemaura medical Inc., Senseonics, and Glysens incorporated.Medtronic, Inc. (Medtronic) is a US-based medical technology company that develops, manufacture and market of a wide range of medical devices, therapies, and services used in the treatment of chronic conditions such as diabetes, vascular disease, neurological disorders, spinal conditions and heart disease. Dexcom performs design, development, and market for continuous glucose monitoring systems for ambulatory and in-hospital use.Abbot diagnostic is a manufacturer of in vitro diagnostics offers a range of medical instruments, tests, and systems for clinics and hospitals. Abbot technology also develops manufactures and supply products of in vitro diagnostics market.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
    • BOTTOM-UP APPROACH
    • TOP DOWN APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY & KEY FINDINGS OF THE STUDY
  4. MARKET OVERVIEW
    • DRIVERS AND IMPACT
      • INCREASE IN DIABETIC POPULATION
      • INCREASE IN HEALTHCARE EXPENDITURE
      • INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
      • TECHNOLOGY INTEGRATION
      • INCREASING CGMS AFFORDABILITY
      • LOW PRICE OF TECHNOLOGY
    • RESTRAIN AND IMPACT
      • HINDERANCE FROM GOVERNMENT REGULATIONS
      • SMBG MANUFACTURERS RESTRAINING CGMS GROWTH
      • INADEQUATE REIMBURSEMENT OPTIONS FOR CGM
      • LACK OF KNOWLEDGE
    • KEY TRENDS
      • DEVELOPMENT OF HIGH-QUALITY WEARABLE DEVICES
      • MOBILE HEALTHCARE MAKING THE DEVICES MORE USER-FRIENDLY
      • INCREASING EFFORTS TOWARDS SPREAD OF AWARENESS
      • INCREASE IN NON-INVASIVE DEVICES
      • ENERGY HARVESTING TECHNOLOGY FOR UNINTERRUPTED USAGE
  1. CGMS MARKET BY COMPONENT TYPE
    • SENSORS
    • TRANSMITTERS AND RECEIVERS
    • INSULIN PUMP
  2. CGMS MARKET BY APPLICATION
    • HOME SETTINGS
    • DIAGNOSTICS AND CLINICS
    • HOSPITALS
  3. SMBG MARKET
  4. SMBG MARKET BY COMPONENT TYPE
    • TEST STRIPS
    • GLUCOSE METER
    • OTHERS
  5. SMBG MARKET BY APPLICATION
    • HOME SETTINGS
    • CLINICS
    • HOSPITALS
  6. KEY ANALYTICAL
    • FORCES ANALYSIS
      • THREAT OF NEW ENTRANT
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • TOP THREE GEOGRAPHIES
    • MERGER AND ACQUISITIONS
  7. REGIONAL ANALYSIS
    • NORTH AMERICA
      • THE US
      • CANADA
    • EUROPE
      • GERMANY
      • THE UK
      • FRANCE
      • REST OF EUROPE (ROE)
    • ASIA-PACIFIC (APAC)
      • CHINA
      • INDIA
      • AUSTRALIA
      • REST OF ASIA-PACIFIC (ROAP)
    • LATIN AMERICA
    • REST OF THE WORLD (ROW)
  8. COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • MEDTRONIC
      • BUSINESS PROFILE
      • PRODUCT PORTFOLIO
      • REVENUE ANALYSIS
      • STRATEGIC INPUTS
      • SCOT ANALYSIS
    • DEXCOM
      • BUSINESS PROFILE
      • PRODUCT PORTFOLIO
      • REVENUE ANALYSIS
      • STRATEGIC INPUTS
      • SCOT ANALYSIS
    • ABBOTT
      • BUSINESS PROFILE
      • PRODUCT PORTFOLIO
      • REVENUE ANALYSIS
      • STRATEGIC INPUTS
      • SCOT ANALYSIS
    • JOHNSON AND JOHNSON
      • BUSINESS PROFILE
      • PRODUCT PORTFOLIO
      • REVENUE ANALYSIS
      • STRATEGIC INPUTS
      • SCOT ANALYSIS
    • INSULET CORP
      • BUSINESS PROFILE
      • PRODUCT PORTFOLIO
      • REVENUE ANALYSIS
      • STRATEGIC INPUTS
      • SCOT ANALYSIS
    • TANDEM DIABETES CARE
      • BUSINESS PROFILE
      • REVENUE ANALYSIS
      • PRODUCT PORTFOLIO
      • STRATEGIES INPUTS
      • SCOT ANALYSIS
    • ECHO THERAPEUTICS INC
      • BUSINESS PROFILE
      • REVENUE ANALYSIS
      • PRODUCT PORTFOLIO
      • STRATEGIES INPUTS
      • SCOT ANALYSIS
    • ROCHE DIAGNOSTICS
      • BUSINESS PROFILE
      • REVENUE ANALYSIS
      • PRODUCT PORTFOLIO
      • STRATEGIES INPUTS
      • SCOT ANALYSIS
    • NEMAURA MEDICAL INC
      • BUSINESS PROFILE
      • REVENUE ANALYSIS
      • PRODUCT PORTFOLIO
      • STRATEGIES INPUTS
      • SCOT ANALYSIS
    • SENSEONICS INC
      • BUSINESS PROFILE
      • REVENUE ANALYSIS
      • PRODUCT PORTFOLIO
      • STRATEGIES INPUTS
      • SCOT ANALYSIS
    • GLYSENS INC
      • BUSINESS PROFILE
      • STRATEGIES INPUTS
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS

 

LIST OF TABLES

TABLE 1 GLOBAL CGMS MARKET BY GEOGRAPHY, 2017-2025(IN US$ MILLION)

TABLE 2 GLOBAL SMBG MARKET BY GEOGRAPHY, 2017-2025 (IN US$ MILLION)

TABLE 3 GLOBAL CGMS MARKET, BY COMPONENT TYPE, 2017-2025(IN US$ MILLION)

TABLE 4 GLOBAL CGMS SENSORS MARKET, 2017-2025(IN US$ MILLION)

TABLE 5 GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)

TABLE 6 GLOBAL CGMS INSULIN PUMP MARKET, 2017-2025(IN US$ MILLION)

TABLE 7 GLOBAL CGMS MARKET, BY APPLICATION 2017-2025 (IN US$ MILLION)

TABLE 8 GLOBAL CGMS HOME SETTINGS MARKET, 2017-2025(IN US$ MILLION)

TABLE 9 GLOBAL CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025(IN US$ MILLION)

TABLE 10 GLOBAL CGMS HOSPITALS MARKET, 2017-2025(IN US$ MILLION)

TABLE 11 IMPORTANT ASPECTS FOR USE OF SMBG DEVICES IN HOME-CARE SETTINGS

TABLE 12 SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICA

TABLE 13 PRODUCT MATRIX FOR LANCETS

TABLE 14 GLOBAL SMBG MARKET, BY COMPONENT TYPE, 2017-2025 (IN US$ MILLION)

TABLE 15 GLOBAL SMBG MARKET 2017-2025 ($ MILLION)

TABLE 16 GLOBAL CGMS MARKET REVENUE, BY REGION, 2017-2025(IN US$ MILLION)

TABLE 17 GLOBAL SMBG MARKET REVENUE, BY REGION, 2017-2025(IN US$ MILLION)

TABLE 18 NORTH AMERICA SMBG MARKET 2017-2025 ($ MILLION)

TABLE 19 EUROPE SMBG MARKET 2017-2025 ($ MILLION)

TABLE 20 GERMANY DIABETIC STATISTICS 2015

TABLE 21 ASIA-PACIFIC SMBG MARKET 2017-2025(US$ MILLION)

 

LIST OF FIGURES

FIGURE 1 GLOBAL CGMS MARKET SHARE, BY COMPONENT TYPE 2016 & 2025 (%)

FIGURE 2 GLOBAL CGMS SENSORS MARKET, 2017-2025(IN US$ MILLION)

FIGURE 3 GLOBAL CGMS TRANSMITTERS AND RECEIVERS MARKET, 2017-2025(IN US$ MILLION)

FIGURE 4 GLOBAL CGMS INSULIN PUMP MARKET, 2017-2025(IN US$ MILLION)

FIGURE 5 GLOBAL CGMS SHARE, BY APPLICATION 2016 & 2025(%)

FIGURE 6 GLOBAL CGMS HOME SETTING MARKET, 2017-2025(IN US$ MILLION)

FIGURE 7 GLOBAL CGMS DIAGNOSTICS AND CLINICAL MARKET, 2017-2025(IN US$ MILLION)

FIGURE 8 GLOBAL CGMS HOSPITALS MARKET, 2017-2025(IN US$ MILLION)

FIGURE 9 GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025(%)

FIGURE 10 GLOBAL SMBG TEST STRIPS MARKET, 2017-2025 (IN US$ MILLION)

FIGURE 11 GLOBAL SMBG GLUCOSE METER MARKET, 2017-2025 (IN US$ MILLION)

FIGURE 12 GLOBAL SMBG OTHERS MARKET, 2017-2025 (IN US$ MILLION)

FIGURE 13 GLOBAL SMBG MARKET SHARE, BY COMPONENT TYPE 2016 & 2025(US$ MILLION)

FIGURE 14 GLOBAL SMBG HOME SETTING MARKET, 2017-2025 (IN US$ MILLION)

FIGURE 15 GLOBAL SMBG CLINICAL MARKET, 2017-2025 (IN US$ MILLION)

FIGURE 16GLOBAL SMBG HOSPITALS MARKET, 2017-2025 (IN US$ MILLION)

FIGURE 17 TOP THREE GEOGRAPHIES 2016

FIGURE 18 GLOBAL GGMS MARKET SHARE, BY GEOGRAPHY 2016 & 2025(%)

FIGURE 19 NORTH AMERICA CGMS MARKET SHARE, BY COUNTRY 2016 & 2025 (%)

FIGURE 20 US CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 21 US SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 22 CANADA CGMS MARKET REVENUE, 2017-2025 (IN USD MILLION)

FIGURE 23 CANADA SMBG MARKET REVENUE, 2017-2025 (IN USD MILLION)

FIGURE 24EUROPE CGMS MARKET SHARE, BY COUNTRY 2016& 2025 (%)

FIGURE 25 GERMANY CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 26 GERMANY SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 27 UK CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 28 UK SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 29 FRANCE CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 30 FRANCE SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 31 REST OF EUROPE (ROE) CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 32 REST OF EUROPE (ROE) SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 33 ASIA-PACIFIC CGMS MARKET REVENUE 2017-2025(US$ MILLION)

FIGURE 34 ASIA-PACIFIC CGMS MARKET SHARE, BY COUNTRY 2016 & 2025 (%)

FIGURE 35 CHINA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 36 CHINA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 37 INDIA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 38 INDIA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 39 AUSTRALIA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 40 AUSTRALIA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 41 REST OF ASIA-PACIFIC CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 42 REST OF ASIA-PACIFIC SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 43 LATIN AMERICA CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 44 LATIN AMERICA SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 45 ROW CGMS MARKET REVENUE, 2017-2025(IN USD MILLION)

FIGURE 46 ROW SMBG MARKET REVENUE, 2017-2025(IN USD MILLION)

 

  1. CGMS MARKET BY COMPONENT TYPE
    • SENSORS
    • TRANSMITTERS AND RECEIVERS
    • INSULIN PUMP
  2. CGMS MARKET BY APPLICATION
    • HOME SETTINGS
    • DIAGNOSTICS AND CLINICS
    • HOSPITALS
  3. SMBG MARKET
  4. SMBG MARKET BY COMPONENT TYPE
    • TEST STRIPS
    • GLUCOSE METER
    • OTHERS
  5. SMBG MARKET BY APPLICATION
    • HOME SETTINGS
    • CLINICS
    • HOSPITALS
  6. REGIONAL ANALYSIS
    • NORTH AMERICA
      • THE US
      • CANADA
    • EUROPE
      • GERMANY
      • THE UK
      • FRANCE
      • REST OF EUROPE (ROE)
    • ASIA-PACIFIC (APAC)
      • CHINA
      • INDIA
      • AUSTRALIA
      • REST OF ASIA-PACIFIC (ROAP)
    • LATIN AMERICA
    • REST OF THE WORLD (ROW)

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.